President and CEO at GelMEDIX.
Earliest Form D on file: Apr 2026
Hydrogel-delivered cell therapy for geographic atrophy
Biotech, Cambridge MA
Signed as President and CEO
$747K
sold of $2.5M offered
Form D
LinkedIn
Reported on an amendment to an earlier filing.
Michael Cima
Director
Nasim Annabi
Parinaz Motamedy
Reza Dana
Browse by sector
Browse by state